ABSTRACT: Osteoporosis is a disease characterized by low bone mass and progressive destruction of bone microstructure, resulting in increasing the risk of fracture. Icariin (ICA) as a phytoestrogen shows osteogenic effects, and the mechanical stimulation has been demonstrated the improving effect on osteoporosis. The objective of this study was to investigate the effect of ICA in combination with constrained dynamic loading (CDL) stimulation on osteoporosis in ovariectomized (OVX) mice. The serum hormone levels, bone turnover markers, trabecular architecture, ulnar biomechanical properties, and the expression of osteoblast-related gene (alkaline phosphatase, ALP; osteocalcin, OCN; bone morphogenetic protein-2, BMP-2; Collagen I (a1), COL1; osteoprotegerin, OPG) and osteoclast-related genes (receptor activators of NF-kB ligand, RANKL; tartrate-resistant acid phosphatase, TRAP) were analyzed. The results showed that ICA þ CDL treatment could increase the osteocalcin (20.85%), estradiol levels (20.61%) and decrease the TRAP activity (26.27%) significantly than CDL treatment. The combined treatment attenuated bone loss and biomechanical decrease more than single use of CDL treatment. ICA þ CDL treatment significantly up-regulated the level of osteoblast-related gene expression and down-regulated the osteoclast-related genes expression; moreover, the combined treatment increased the ratio of OPG/RANKL significantly compared to ICA (72.83%) or CDL (65.63%) treatment alone. The present study demonstrates that icariin in combination with constrained dynamic loading treatment may have a therapeutic advantage over constrained dynamic loading treatment alone for the treatment of osteoporosis, which would provide new evidence for the clinical treatment of osteoporosis. Osteoporosis is a common health problem characterized by bone mass reduction, increased bone fracture risk, and potential bone architecture alterations, which mainly affects postmenopausal women and elderly people resulting in hip and vertebral fracture.
Osteoporosis is a common health problem characterized by bone mass reduction, increased bone fracture risk, and potential bone architecture alterations, which mainly affects postmenopausal women and elderly people resulting in hip and vertebral fracture. [1] [2] As the increasing of aging population, osteoporosis has become a global health problem, and it is estimated that one in three women and one in five men are affected with osteoporosis (International Osteoporosis Foundation, http://www.iofbonehealth. org/). Estrogen deficiency, a main factor in inducing osteoporosis in women, could increase bone turnover and osteoclastic resorption, exceeding the rate of osteoblastic formation, result in a loss of bone mass and decrease bone strength in women. 3 Estrogen replacement therapy is a classical therapeutic approach in preventing the development of osteoporosis and reducing the risk of fracture in postmenopausal women. 4 However, estrogen replacement therapy could increase the risks of breast cancer, endometrial cancer, and other cardiovascular diseases. Therefore, there is an urgent need to explore natural alternatives for prevention of bone loss and fracture risk induced by osteoporosis with less side effects, such as Chinese herbal medicine formula. 5 Selective estrogen receptor mudulators (SERMs) are possibly a new alternative for postmenopausal therapy. Unlike estrogens, which are uniformly agonists, and antiestrogens, the SERMs exert selective agonist or antagonist effects on various estrogen target tissues. 6 Phytoestrogen (PE), appeared to have SERM-like properties, is a general term used to define classes of compounds with weak estrogenic or antiestrogenic activity and are either of plant origin or derived from the in vivo metabolism of precursors present in several plants eaten by human beings. These compounds included certain isoflavonoids, flavonoids, stilbenes, and lignans. 7 Icariin is the phytoestrogen flavonoid isolated from Herba epimedii (Epimedium brevicornum Maxim.) with SERMs effect, which is used in traditional Chinese medicine for treatment of kidney, joints, and other disorders. And the studies showed that Epimedium brevicornum Maxim.-derived phytoestrogen flavonoids (EPFs) exerted beneficial effects on preventing bone loss in postmenopausal women, without resulting in a hyperplasia effect on the endometrium. 8 The previous studies showed that icariin could induce osteoblast proliferation, differentiation, and mineralization though estrogen receptor-mediated extracellular signal-regulated kinases (ERK) and c-Jun N-terminal kinase (JNK) signal activation. 9 Moreover, icariin inhibited osteoclast differentiation and bone resorption by suppression of MAPKs/ NF-kB. 10 The recent study showed that icariin has strong osteogenic activity, inducing osteogenic differentiation and inhibiting resorption by osteoclasts in ovariectomized rats. 11 Similarly, the regular load is important for maintaining the integrity of bone described by Wolff's law on the relationship between bone morphology and mechanical load. 12 Bone remodeling is a complicated biological process depending on genetic, hormonal, and mechanical environment. 13 Mechanical loading plays an important role in the regulation of bone remodeling as suitable mechanical stimulation could maintain normal bone volume.
14 Mechanical loading with a constrained amplitude and frequency could cause obvious osteogenesis and improve the histomorphology and mechanical behavior of cancellous and cortical bone. 15 Our previous study showed that constrained dynamic loading could prevent ovariectomy-induced osteoporosis by facilitating osteogenesis, improving trabecular microstructure and enhancing bone mechanical properties. 16 Mechanical strain could enhance both ERa and ERb expressions to facilitate structurally appropriate bone formation. 17 Moreover, the intermittent mechanical strain (IMS) promoted osteogenic differentiation of BMSCs from ovariectomized rats by activating Runt-related transcription factor 2 (Runx2) and ERK1/2-MAPK signaling pathway. 18 The combination of drugs and mechanical stimulation could exert the important regulation of bone remodeling than drugs or mechanical stimulation alone. The combined treatment with naringin and treadmill exercise have an additive effect on reducing the risk of fracture for osteoporosis associated with estrogen deficiency, 19 and low-magnitude whole-body vibration combined with alendronate also improved the trabecular architecture in ovariectomized rats. 20 Our previous study has shown that mechanical strain-induced osteoblast proliferation, differentiation, and mineralization by activating NF-kB pathway in MC3T3-E1 cells, 21 moreover, the combination of icariin and mechanical strain stimulation improved osteoinductive potential by up-regulating the mRNA and protein expressions of ALP, OCN and Col I in osteoblastlike cells in vitro. 22 The purpose of this study was to evaluate the effect of icariin combined with constrained dynamic loading treatment on osteoporosis in ovariectomized mice. We have investigated different treatments on osteoblastic formation and osteoclastic resorption in osteoporotic bone induced by ovariectomy in mice, which would provide a new method for prevention and treatment of osteoporosis. 
MATERIALS AND METHODS

Reagents and Animals
Experimental Design
The experimental animals were randomly assigned to five groups and four groups were removal of the bilateral ovaries (OVX). The mice in the sham group (n ¼ 16) were incision and sutured without removal of the ovaries. One month after post-surgery, the four OVX group treated with vehicle (VEH, in this study it was PBS, n ¼ 16), icariin (ICA, intragastric administration 200 mg/Kg, once 3rd day, n ¼ 16), constrained dynamic loading (CDL, n ¼ 16), and icariin plus constrained dynamic loading (ICA þ CDL, n ¼ 16) for 4 weeks. The constrained dynamic loading in mice was performed as our previously reported 17 with an ulna diaphyseal peak strain 2500 me and a frequency of 15 Hz for 15 min every 3rd day over a period of 4 weeks. After 4 weeks of treatment, the animals were sacrificed, and blood samples were collected for serum isolation. The ulnar bones were dissected and divested of soft tissue for analysis of trabecular microarchitecture.
Serum Hormone Measurement and Bone Turnover Markers Evaluation
The serum was separated by centrifugation at 1,000g for 10 min and then stored at À80˚C until assay for E 2 , FSH, and LH. Serum E 2 , FSH, and LH concentrations were determined using ELISA Kit from Cloud-Clone Corp (n ¼ 8). (Houston, TX). Bone turnover markers were evaluated by analyzing serum osteocalcin (OCN), alkaline phosphatase (ALP) activity and tartrate-resistant acid phosphatase (TRAP) levels. Serum osteocalcin levels were measured using an enzyme-linked immunosorbent assay (Osteocalcin ELISA kit, Cloud-Clone Corp., Houston, TX) according to the manufacturer's instruction. Serum ALP and TRAP levels were measured using enzyme activity assay (Alkaline phosphatase assay kit and Tartrate Resistant Acid Phosphatase assay kit, Nangjing, China) according to the manufacturer's instructions.
Trabecular Bone Microarchitecture
The trabecular bone microarchitecture of the proximal ulnae was scanned using a micro-CT system (SkyScan 1076 in vivo micro-CT, Bruker, Kontich, Belgium). Ulnae were collected and all muscle tissues were removed from the bone. The ulna was placed perpendicular to the plane of scanning. The scanning region used for the structural evaluation was defined as a 2-mm region, which started from 2 mm distal to the proximal growth plate (n ¼ 4). The X-ray source was set at a voltage of 50 kV and a current of 200 mA and filtered with a 0.5 mm aluminum filter. Resolution for all samples was set at 9 mm, a rotation step of 0.8˚and a rotation angle was 180˚. Approximately 300 slices were obtained and data were reconstructed at a step size of four provided by Skyscan. The following parameters were measured: Bone mineral density (BMD, g/cm 3 ), trabecular bone volume fraction (bone volume/ tissue volume, BV/TV, %), trabecular thickness (Tb.Th, mm), trabecular number (Tb.N, #/mm) and trabecular separation (Tb.Sp, mm), trabecular pattern factor (Tb.Pf, #/mm).
Bone Biomechanical Testing
The isolated right ulnae were assessed with the classical three-point bending test by using a Dynamic Mechanical Analyzer (INSTRON 5865, Norwood, MA). Prior to mechanical testing, the right ulnae were thawed at room temperature for at least 1 h (n ¼ 4). The mechanical properties of the ulna were determined by the classical three-point bending test with the following parameters: 10 mm gauge length, 0.5 N preload and 3 mm/min loading rate, outputting fracture displacement/strain, fracture stress and fracture energy.
Bone Histomorphometry
Ulnae were dehydrated in graded concentrations of ethanol and embedded in paraffin. Sagittal sections for trabecular bone were obtained from the distal ulnae at a thickness of 5mm and stained with hematoxylin and eosin (H&E). The stained sections of each test sample were examined using light microscopy (OLYMPUS, Japan). The trabecular bone of the proximal ulnae was assessed for the quality of bone and trabecular density, according to histological score criteria of reference. 23 
Real-Time RT-PCR Analysis
Total RNA of whole ulnae tissue was isolated using a Sangon UNIQ-10 column Trizol total RNA extraction kit according to instructions of the manufacture (n ¼ 4). The real-time RT-PCR oligonucleotide primers sequences were shown in Table 1 . The reactions were setup in duplicates in 25 ml total volumes with 1 ml of template, 1 ml of each primer, and 12.5 mL of FastStart Universal SYBR Green Master (ROX) (Roche). The PCR cycle was as follows: 95˚C for 10 min, 40 cycles of 95˚C for 15 s, 60˚C for 1 min with a melt curve analysis performed at the end of each experiment to verify that a single product per primer pair was amplified. The amplification and analysis was performed using an ABI Prism 7500 real-time PCR system. Samples were analyzed using the relative C T method. The fold increase or decrease was determined after normalizing to a house-keeping gene using 2
À44C
T . [24] [25] [26] Statistical Analysis All values were represented as mean AE standard deviation (SD). Statistically significant differences between groups were determined using Origin Pro 8.0 (Northampton, MA) by one way analysis of variance (ANOVA) followed by and Tukey's post hoc test. The criterion for statistical significance was p < 0.05.
RESUTLS
The Serum E 2 , FSH, LH Level Measurements After 4 weeks of treatment, the animals were sacrificed, and blood samples were collected for serum isolation. The secretion of serum E 2 was down-regulated (54.57%) significantly and the levels of serum FSH, LH were increased (51.6%, 13.4%, respectively) significantly after the ovariectomy surgery. The level of serum E 2 was significantly higher in ICA or ICA þ CDL treatment groups compared to the OVX treatment group (p < 0.05). Compared to CDL treatment group, the ICA þ CDL treatment could increase the level of serum E 2 , but there was no significance (p > 0.05). The level of FSH was significantly lower in ICA þ CDL treatment groups, and the level of LH was significantly lower in ICA or ICA þ CDL treatment groups compared to the OVX treatment group (p < 0.05). There were no significances in FSH and LH levels between CDL and OVX Figure 3 . In OVX group, the BMD were significantly attenuated and the bone micro-architecture severely impaired, moreover, the trabeculae were thin and less dense, and the connectivity was reduced compared with the sham groups. The BV/TV, Tb. N, and Tb. Th were significantly decreased and the Tb. Sp, Tb. Pf were increased compared with the mice in the sham group (p < 0.05), indicating the successful establishment of the osteoporotic model. CDL, ICA, or ICA þ CDL treatment showed excellent effects in reversing bone morphologic parameters of BMD, Tb.N, BV/TV, Tb.Th decrease and Tb.Sp, Tb.Pf increase, moreover, the ICA þ CDL treatment had the most excellent effects on decreasing of Tb.Sp and increasing of Tb.N compared to CDL treatment alone (p < 0.05). Effect of ICA þ CDL Treatment on Ulnae Biomechanical Properties As shown in Figure 4 , the ulnae macro-mechanics parameters (fracture displacement, fracture strain, fracture load and fracture energy) were significantly lower in the OVX group compared with the sham group (p < 0.05). A statistically significant increase in biomechanical strength was observed in CDL, ICA, or ICA þ CDL treatment groups compared to OVX group, evidenced by increased levels of the fracture displacement, fracture strain, fracture load, and fracture energy (p < 0.05). The ICA þ CDL treatment groups showed the greatest biomechanical strength on increasing the levels of fracture strain and fracture load compared to CDL treatment groups alone (p <0.05). However, there was no significance on increasing the levels of fracture displacement and fracture energy by ICA þ CDL treatment groups compared to CDL treatment groups. Compared to ICA treatment groups, there was also no significance by ICA þ CDL treatment groups on the biomechanical strength (p > 0.05).
Effect of ICA þ CDL Treatment on Bone Morphology
The micro-architectural of the non-decalcified ulna trabecular bone was determined by H&E staining. As shown in Figure 5 , tissue from the sham group revealed normal compactness of the trabecular meshwork, but the trabecular region was small, thin, and sparse in the OVX group, resulting in widened intertrabecular spaces. Compared to the OVX group, the trabecular bones were thickened, the number of trabecula was increased, and trabecular connections were enhanced in CDL or ICA treatment groups. However, the trabecular rods were slightly smaller, and there were still apparent signs of resorption, fractures and incomplete connections. Fractures and absorption 
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were reduced, and the bone trabeculae were more neatly and uniformly arranged in ICA þ CDL treatment group compared with those in the OVX group. Furthermore, the trabecular bones were thickened, the number was increased, and the connections were compact. The histological score (Fig. 5F ) revealed a greater effect of ICA þ CDL treatment on bone quality compared with the other treatments, especially for CDL treatment alone (p < 0.05). The results of bone histomorphometric analysis and histological score data was shown in Table S1 .
Effect of ICA þ CDL Treatment on ALP, OCN, BMP-2, and COL1 mRNA Expression The mRNA expression of ALP, OCN was up-regulated in the OVX group compared to the sham group, while the mRNA expression of BMP-2, COL1 was downregulated in in the OVX group compared to the sham group. The CDL or ICA treatment groups could upregulate the mRNA expression of OCN, BMP-2, COL1, but there was no significance compared to the OVX group. The ICA þ CDL treatment group could upregulate the mRNA expression of OCN, BMP-2, COL1 significantly compared to the OVX group (p < 0.05). The ICA þ CDL treatment group could up-regulate the mRNA expression of OCN and COL1 significantly compared to the CDL treatment group (p < 0.05), but there was no significance compared to ICA treatment group. The mRNA expression of BMP-2 was up-regulated significantly by ICA þ CDL treatment compared to ICA treatment (p < 0.05). The mRNA expression of TRAP was up-regulated significantly about four times in the OVX group compared to the sham group (p < 0.05), and the CDL or ICA, ICA þ CDL treatment groups could down-regulate the mRNA expression (26.98%, 33,34%, and 51.85%, respectively) of TRAP significantly compared to the OVX group (p < 0.05) (Fig. 6) . The mRNA expression of TRAP was down-regulated significantly (34.06%, 27.78%, respectively) by ICA þ CDL treatment compared to CDL or ICA treatment alone (p < 0.05).
Effect of ICA þ CDL Treatment on OPG/RANKL Ratio OPG and RANKL play a key role in regulating osteoporosis. OPG level in OVX-induced osteoporotic model was decreased (34.79%) compared with sham group, whereas, RANKL level was increased (13.32%) in the model group (Fig. 7) . The CDL or ICA treatment groups could up-regulate the mRNA expression of OPG and down-regulate the mRNA expression of RANKL, but there was no significance compared to the OVX group. The ICA þ CDL treatment group could up-regulate the mRNA expression of OPG (46.09%) and down-regulate the mRNA expression of RANKL (47.13%) significantly compared to the OVX group (p < 0.05). The CDL, ICA, and ICA þ CDL treatment group could up-regulate the OPG/RANKL ratio significantly compared to the OVX group (p < 0.05). Moreover, the ICA þ CDL treatment group could up-regulate the OPG/RANKL ratio (65.63%, 72.83%) significantly compared to CDL or ICA treatment alone (p < 0.05).
DISCUSSION
Due to undesirable side-effects (such as irregular bleeding) and concerns about safety (especially possible increased risk of breast cancer) of estrogen replacement therapy, selective estrogen receptor modulators (SERMs) might provide a new alternative for postmenopausal therapy. Phytoestrogens, such as isoflavonoids, flavonoids, have both estrogenic and antiestrogenic effects, like SERMs. 6 Icariin, a natural flavonoid glucoside isolated from Herba epimedii, has a definite anti-osteoporotic effect in ovariectomized rats, 27 and our previous study showed that the constrained dynamic loading could improve trabecular microstructure as well as mechanical property in ovariectomized mice. 16 Mechanical loads provide a directional influence to cells during development, and 
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osteocytes are considered to be likely candidates for sensing load because of their distribution throughout the bone matrix, their ability to respond to strain with biochemical signals, which could active the effector cells (osteoclasts and osteoblast) to influence the bone remodeling. 28, 29 The present study is the continued study to investigate the effect of icariin in combination with constrained dynamic loading treatment in ovariectomized mice. In present study, we found that ICA þ CDL treatment exhibited greater therapeutic effects on osteoporosis than CDL alone in OVX mice, with significantly increased OCN and decreased TRAP levels identified in serum analysis, the highest values of Tb.N in micro-CT evaluation, the strongest effects on ulnar mid-shaft strength in biomechanical tests, significantly down-regulated the mRNA expression of TRAP, especially the expression of OPG/RANKL ratio. These results indicated that the combined treatment of iacriin and constrained dynamic loading stimulation had an additive effect on osteoporosis reduction in OVX mice.
As a main hormone secreted from ovary, E 2 plays an important role in the gonad development through paracrine/autocrine pathways. FSH and LH are essential for steroidogenesis and follicular development in the ovary. The preovulation secretion of FSH and LH is negatively regulated by circulating E 2 with the feedback control system of the hypothalamic-pituitary-ovarian axis. 30 In the current study, ICA þ CDL treatment could significantly increase serum E 2 levels and attenuate the elevated serum LH and FSH levels resulting from the removal of E 2 in OVX rats, indicating that ICA þ CDL treatment has a beneficial role in regulating hypothalamic-pituitary function, shifting the endocrine dynamic towards a more physiologically favorable balance. There were no significances in FSH and LH levels between CDL and OVX groups, indicating that ICA played a main role and CDL could enhance the estrogenic effect of ICA when combined application of ICA and CDL.
Biochemical markers of bone turnover have been determined for the evaluation of the status of bone remodeling. 31 Serum levels of ALP and OCN are known as serum markers reflecting osteoblastic differentiation and bone formation, while serum TRAP serves similar roles in monitoring bone resorption. 32 After OVX, the serum levels of ALP and OCN were significantly increased, which indicated an increased bone formation. This was consistent with the reference that estrogen deficiencyinduced osteoporosis was high turnover type of osteoporosis. 33 Moreover, the levels of TRAP increased significantly after OVX compared to sham group. Further evidence suggests that early the ICA þ CDL treatment could increase the bone turnover by increasing bone formation and decreasing bone resorption, which was evidenced by the significantly increased serum levels of OCN and significantly decreased serum levels of TRAP on the ICA þ CDL treatment group compared to the corresponding pretreatment OVX group, respectively. There was no significance on serum levels of ALP between the ICA þ CDL treatment group and OVX group. The present study aimed to investigate the early treatment for estrogen deficiency-induced osteoporosis, the long-term treatment might decrease the bone turnover by decreasing bone formation and bone resorption, the furthermore research need proceeded.
The bone tissue pathology and the morphology of bone microstructure changed markedly in the OVX mice. Bone microstructure is an important factor affecting the quality of bone. The trabecular number was not markedly increased and still prone to fracture and resorption in the ICA or CDL group, but the trabecular bones were significantly thicker. The bone trabeculae of mice in the ICA þ CDL treatment group were more neatly and uniformly arranged. Furthermore, the trabecular bones were thickened, the number bone trabeculae of was increased, and the connections were compact.
Compared with histological analyses, micro-CT could directly measure bone micro-architecture without relying on stereological models, and it is now regarded as the important method for the evaluation of bone morphology and micro-architecture in small animal models. 34 Bone loss and decreased bone quality is the hallmark of osteoporotic bone. BMD represented the golden standard to diagnose osteoporosis. 35 Preservation of trabecular microarchitecture significantly contributes to bone strength and reduces fracture risk. 36 In our study, BMD was markedly decreased in the OVX group compared with the sham group. The improved BMD during the 4-weeks ICA þ CDL treatment indicated that ICA þ CDL treatment could prevent the bone loss induced by ovariectomies. Both BMD and trabecular bone microarchitecture could improve bone strength. To compare the different effect of the ICA, CDL, and ICA þ CDL treatment on the bone parameters of ovariectomized mice was one aim of the study. ICA, CDL, and ICA þ CDL treatment showed excellent effects in reversing bone morphologic parameters of BMD, Tb.N, BV/TV, Tb.Th decrease and Tb.Sp, Tb.Pf increase, furthermore, the ICA þ CDL treatment had the most excellent effects compared to ICA or CDL treatment alone. The data obtained from micro-CT analysis of proximal ulna showed that the ICA þ CDL treatment was more effective not only in preserving bone mass but also in rescuing the deterioration of bone microarchitecture associated with OVX mice. In addition, biomechanical analysis of bone could provide important information on the integrity of bone function. Our findings indicated that the ICA þ CDL treatment could significantly improve the fracture displacement, fracture strain, fracture load, and fracture energy of ulna in OVX mice than ICA or CDL treatment alone. The results of micro-CT and biomechanical properties analysis verified the best inhibitory effects of the ICA þ CDL treatment on bone loss resulted from estrogen-deficiency. The present study performed one time point (1 month) to detect the biomarkers and investigate the bone structure and mechanical properties, which was coincident with our previous study. However, this is also the limitations of the study, more time point, even 2 months, 4 months, should be considered in the further research, which could be more convinced in supporting for the bone structure and mechanical properties.
It is well-known that bone morphogenetic proteins (BMPs) play a critical role in osteogenic differentiation. 37 Especially BMP-2, one of the most important stimulators in bone formation among BMPs, has shown a strong osteoinductive capacity. 38 In the process of bone formation, osteoblasts undergo three sequential stages: Proliferation, matrix maturation, and mineralization. COLI, ALP, and OCN are biochemical markers in different stages of osteoblasts differentiation. 39 The present study showed that the ICA þ CDL treatment could significantly up-regulated the mRNA expression of BMP-2 in ovariectomized mice, and then up-regulated the mRNA expression of ALP, COL1, and OCN, which promoted the osteoblast differentiation and bone formation. RANKL has been shown to have a significant role in promoting bone resorption by interacting with receptor activator of nuclear factor kB (RANK) on osteoclasts to improve osteoclast differentiation and activation. 40 OPG is an endogenous antagonist of RANKL and inhibits RANKL action by acting as a soluble decoy receptor, thus balancing bone turnover. 41 The OPG/RANKL ratio is important for bone resorption and plays a critical role in the treatment of osteoporosis. 42 We found that the ICA þ CDL treatment increased OPG mRNA expression and reduced RANKL mRNA expression, suggesting that the ICA þ CDL treatment inhibits osteoclast differentiation by increasing the OPG/ RANKL ratio, which may be a major mechanism for the increased bone formation and decreased bone resorption.
In conclusion, this study suggested that the combination of ICA þ CDL has greater effects on osteoporosis than either monotherapy in OVX mice. ICA þ CDL produced the strongest effects on BMD, Tb.N, Tb.Th, and bone strength. ICA þ CDL increased serum levels of OCN and decreased TRAP levels in bone metabolism, and significantly down-regulated the mRNA expression of TRAP and the OPG/RANKL ratio. These results indicate that ICA combined with CDL has an additive effect on osteoporosis associated with estrogen deficiency, and could potentially reduce the risk of fracture.
